News
Alkermes outlined plans to move its NT1 drug candidate, alixorexton, into phase 3 after posting results from the midstage ...
Helen's husband Brent Arthur said: "We were told Helen had a brain tumour, which was a complete shock. The doctors said most ...
A mum-of-two died from an aggressive brain tumour after her back pain was initially diagnosed as a trapped nerve. Helen ...
Viatris reported that its MR-139 ophthalmic ointment failed to meet its primary endpoint in a Phase III blepharitis trial, while advancing its MR-141 and MR-142 candidates in presbyopia and night ...
2h
Stories by SWNS on MSNGran dies after aggressive brain tumour was mistaken for trapped nerve
A mum-of-two died from an aggressive brain tumour after her back pain was initially misdiagnosed as a trapped nerve. Helen Arthur, 57, first became unwell on Good Friday in April 2019, experiencing ...
VTRS slides after phase III trial failure for blepharitis drug MR-139, adding pressure to an already struggling stock.
1h
HealthDay on MSNGLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional ...
Many common bedroom items can negatively impact sleep and well-being. Mold-prone plants, workout equipment, and dirty laundry ...
A GRAN passed away after her back pain was initially dismissed as a ‘trapped nerve’. Helen Arthur, 57, first became unwell on Good Friday in April 2019, experiencing persistent back ...
Viatris announces phase 3 study of MR-139 for blepharitis fails to meet its primary endpoint: Pittsburgh Monday, July 21, 2025, 11:00 Hrs [IST] Viatris Inc., a global healthcare c ...
Viatris’ investigational blepharitis ointment failed to achieve the primary endpoint in its Phase III trial, prompting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results